Environmental sustainability in gynecologic oncology.

Autor: Swiecki-Sikora AL; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, 800 Rose Street, Lexington, KY 40536, United States., Becker MV; Department of Obstetrics and Gynecology, University of Kentucky, 800 Rose Street, Lexington, KY 40536, United States., Harbin LM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, 800 Rose Street, Lexington, KY 40536, United States., Knapp E; Office of Technology Commercialization, University of Kentucky, 800 Rose Street, Lexington, KY 40536, United States., Nair RT; Department of Radiology, University of Kentucky, 800 Rose Street, Lexington, KY 40536, United States., Guzman MI; Department of Chemistry, University of Kentucky, 506 Library Dr., Lexington, KY 40536, United States., Atwood DA; Department of Chemistry, University of Kentucky, 506 Library Dr., Lexington, KY 40536, United States., Ali SZ; Department of Anesthesiology, University of Kentucky, 800 Rose Street, Lexington, KY 40536, United States., Dietrich CS; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, 800 Rose Street, Lexington, KY 40536, United States.

Publikováno v: Gynecologic oncology reports [Gynecol Oncol Rep] 2024 Sep 10; Vol. 55, pp. 101499. Date of Electronic Publication: 2024 Sep 10 (Print Publication: 2024).

Accelerating inhibitor discovery for deubiquitinating enzymes.

Autor: Chan WC; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Liu X; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Magin RS; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Girardi NM; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Ficarro SB; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Emergent Drug Targets, Dana-Farber Cancer Institute, Boston, MA, USA., Hu W; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Tarazona Guzman MI; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Starnbach CA; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Felix A; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Adelmant G; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA, USA., Varca AC; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Hu B; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Bratt AS; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., DaSilva E; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Schauer NJ; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Jaen Maisonet I; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Dolen EK; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Ayala AX; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Marto JA; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA. jarrod_marto@dfci.harvard.edu.; Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA, USA. jarrod_marto@dfci.harvard.edu.; Center for Emergent Drug Targets, Dana-Farber Cancer Institute, Boston, MA, USA. jarrod_marto@dfci.harvard.edu.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. jarrod_marto@dfci.harvard.edu., Buhrlage SJ; Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA, USA. saraj_buhrlage@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. saraj_buhrlage@dfci.harvard.edu.; Center for Emergent Drug Targets, Dana-Farber Cancer Institute, Boston, MA, USA. saraj_buhrlage@dfci.harvard.edu.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. saraj_buhrlage@dfci.harvard.edu.

Publikováno v: Nature communications [Nat Commun] 2023 Feb 08; Vol. 14 (1), pp. 686. Date of Electronic Publication: 2023 Feb 08.

Oxidation of Catechols at the Air-Water Interface by Nitrate Radicals.

Autor: Rana MS; Department of Chemistry, University of Kentucky, Lexington, Kentucky40506, United States., Guzman MI; Department of Chemistry, University of Kentucky, Lexington, Kentucky40506, United States.

Publikováno v: Environmental science & technology [Environ Sci Technol] 2022 Nov 15; Vol. 56 (22), pp. 15437-15448. Date of Electronic Publication: 2022 Nov 01.

Interfacial Oxidative Oligomerization of Catechol.

Autor: Guzman MI; Department of Chemistry, University of Kentucky, Lexington, Kentucky40506, United States., Pillar-Little EA; Department of Chemistry, University of Kentucky, Lexington, Kentucky40506, United States., Eugene AJ; Department of Chemistry, University of Kentucky, Lexington, Kentucky40506, United States.

Publikováno v: ACS omega [ACS Omega] 2022 Sep 22; Vol. 7 (40), pp. 36009-36016. Date of Electronic Publication: 2022 Sep 22 (Print Publication: 2022).

Reactivity of aminophenols in forming nitrogen-containing brown carbon from iron-catalyzed reactions.

Autor: Al-Abadleh HA; Department of Chemistry and Biochemistry, Wilfrid Laurier University, Waterloo, ON, N2L 3C5, Canada. halabadleh@wlu.ca., Motaghedi F; Department of Chemistry and Biochemistry, Wilfrid Laurier University, Waterloo, ON, N2L 3C5, Canada., Mohammed W; Department of Chemistry and Biochemistry, Wilfrid Laurier University, Waterloo, ON, N2L 3C5, Canada., Rana MS; Department of Chemistry, University of Kentucky, Kentucky, 40506, USA., Malek KA; Department of Chemical and Biomolecular Engineering, University of Maryland, College Park, MD, 20742, USA., Rastogi D; Department of Chemical and Biomolecular Engineering, University of Maryland, College Park, MD, 20742, USA., Asa-Awuku AA; Department of Chemical and Biomolecular Engineering, University of Maryland, College Park, MD, 20742, USA. asaawuku@umd.edu., Guzman MI; Department of Chemistry, University of Kentucky, Kentucky, 40506, USA. marcelo.guzman@uky.edu.

Publikováno v: Communications chemistry [Commun Chem] 2022 Sep 19; Vol. 5 (1), pp. 112. Date of Electronic Publication: 2022 Sep 19.